{
    "clinical_study": {
        "@rank": "134648", 
        "arm_group": {
            "arm_group_label": "Rhinix Nasal Filters", 
            "arm_group_type": "Experimental", 
            "description": "All included will receive rhinix nasal filters"
        }, 
        "brief_summary": {
            "textblock": "This study will investigate usability and compliance related to rhinix nasal filters for the\n      treatment of seasonal allergic rhinitis (hay fever) during the natural grass pollen season\n      in Denmark."
        }, 
        "brief_title": "Compliance and Usability Study Evaluating RHINIX\u2122 Nasal Filters", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Seasonal Allergic Rhinitis", 
        "condition_browse": {
            "mesh_term": [
                "Rhinitis, Allergic, Seasonal", 
                "Rhinitis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Motivated to try a different treatment approach to seasonal allergic rhinitis\n             (documented by answering the call-out by Astma-Allergi Danmark)\n\n          -  Indicates having seasonal allergic rhinitis to grass via online questionnaire\n\n          -  Informed consent (by email acceptance after having received information on the trial)\n\n          -  Assess to internet and email\n\n        Exclusion Criteria:\n\n          -  Improper fit of the Rhinix\u2122 device"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "1500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02108379", 
            "org_study_id": "00002"
        }, 
        "intervention": {
            "arm_group_label": "Rhinix Nasal Filters", 
            "intervention_name": "Rhinix Nasal Filters", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 12, 2014", 
        "location": {
            "contact": {
                "email": "ptkh@mil.au.dk", 
                "last_name": "Peter Kenney"
            }, 
            "facility": {
                "address": {
                    "city": "Aarhus", 
                    "country": "Denmark", 
                    "zip": "8000"
                }, 
                "name": "Aarhus University, School of Public Health, Department of Environmental & Occupational Medicine"
            }, 
            "investigator": {
                "last_name": "Torben Sigsgaard, Prof MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "1", 
        "official_title": "An Open-label Outpatient In-season Study Assessing Compliance and Usability of Rhinix\u2122 Nasal Filters", 
        "other_outcome": [
            {
                "description": "In week 1: To assess the correlation between symptom severity at screening and likelihood of answering that they will definitely/likely continue using the product.", 
                "measure": "Week 1: Correlation of use and allergy severiy", 
                "safety_issue": "No", 
                "time_frame": "One assessment at the end of the 1st week of use"
            }, 
            {
                "description": "Week 2: To assess the correlation between symptom severity at screening and likelihood of answering that they will definitely/likely continue using the product.", 
                "measure": "Week 2: Correlation between use and allergy severity", 
                "safety_issue": "No", 
                "time_frame": "One assessment at the end of the 2nd week of use"
            }, 
            {
                "description": "In week 1: To assess whether use of RHINIX has led to a perceived decrease in use of medication.", 
                "measure": "Week 1: Perceived decrease in medication", 
                "safety_issue": "No", 
                "time_frame": "One assessment after the 1st week of use"
            }, 
            {
                "description": "Week 2: To assess whether use of RHINIX has led to a perceived decrease in use of medication.", 
                "measure": "Week 2: Perceived decrease in medication", 
                "safety_issue": "No", 
                "time_frame": "One assessment after 2nd week of use"
            }
        ], 
        "overall_contact": {
            "email": "ts@mil.au.dk", 
            "last_name": "Torben Sigsgaard, Prof MD", 
            "phone": "+4587168013"
        }, 
        "overall_contact_backup": {
            "email": "ptkh@mil.au.dk", 
            "last_name": "Peter S. Kenney, MD-PHD student", 
            "phone": "+4561719898"
        }, 
        "overall_official": {
            "affiliation": "Aarhus University, School of Public Health, Dept. of Environmental & Occupational Medicine", 
            "last_name": "Torben Sigsgaard, Prof MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: Danish Dataprotection Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "In week 1: The proportion of subjects that rate that they will definitely or are likely to continue using RHINIX after the study is over given that they have stated that they have tried the device.", 
                "measure": "Week 1 likelihood of continued use of RHINIX after study end.", 
                "safety_issue": "No", 
                "time_frame": "1 assessment at the end of the 1st week of use."
            }, 
            {
                "description": "In week 2: The proportion of subjects that rate that they will definitely or are likely to continue using RHINIX after the study is over given that they have stated that they have tried the device.", 
                "measure": "Week 2 likelihood of continued use of RHINIX after study end.", 
                "safety_issue": "No", 
                "time_frame": "1 assessment at the end of the 2nd week of use."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02108379"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "In week 1: The proportion of subjects who are completely or somewhat satisfied with RHINIX given that they have used the product.", 
                "measure": "Week 1 Satisfaction with RHINIX", 
                "safety_issue": "No", 
                "time_frame": "1 assessment at the end of the 1st week"
            }, 
            {
                "description": "In week 2: The proportion of subjects who are completely or somewhat satisfied with RHINIX given that they have used the product.", 
                "measure": "Week 2 satisfaction with RHINIX", 
                "safety_issue": "No", 
                "time_frame": "One assessment at the end of the 2nd week"
            }, 
            {
                "description": "In week 1: The proportion of subjects who state that RHINIX has helped \"to a very high degree\" or \"to a high degree\" in controlling their hay fever symptoms given that they have used the product", 
                "measure": "Week 1: RHINIX Control", 
                "safety_issue": "No", 
                "time_frame": "One assessment at the end of the 1st week of use"
            }, 
            {
                "description": "In week 2: The proportion of subjects who state that RHINIX has helped \"to a very high degree\" or \"to a high degree\" in controlling their hay fever symptoms given that they have used the product", 
                "measure": "Week 2: RHINIX Control", 
                "safety_issue": "No", 
                "time_frame": "One assessment at the end of the 2nd week of use."
            }
        ], 
        "source": "University of Aarhus", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Rhinix ApS", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Astma-Allergi Danmark", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2014", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}